Jameson Legal

 

Resource

 

 

 

 

 

 

 

 

 

 

 

SVC-AG für KMU Risikokapital acquires minority stake in Stratpharma AG

19 Mar 2015

Within a new financing round, SVC-AG für KMU Risikokapital acquires a minority stake in Stratpharma AG which specializes in the development and commercialization of innovative dermatological products.

Walder Wyss advices Stratpharma AG and Stratpharma AG's shareholders in connection with the transaction. The Walder Wyss team includes Alexander Gutmans (Partner, Corporate/M&A) and Robert von Rosen (Managing Associate, Corporate/M&A).

Matter Type
Fund/Investment Management
Industry
Healthcare, Life Sciences & Chemicals
News Category
M&A